A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn’s disease

BACKGROUND: There is considerable interest in the possible importance of the gut microflora in the pathophysiology of the inflammatory bowel diseases (IBD) ulcerative colitis (UC) and Crohn’s disease (CD). Probiotics offer a potential adjuvant treatment in these patients by modifying the intestinal...

Descripción completa

Detalles Bibliográficos
Autores principales: Bjarnason, Ingvar, Sission, Guy, Hayee, Bu’Hussaine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554453/
https://www.ncbi.nlm.nih.gov/pubmed/31054010
http://dx.doi.org/10.1007/s10787-019-00595-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554453/
https://www.ncbi.nlm.nih.gov/pubmed/31054010
http://dx.doi.org/10.1007/s10787-019-00595-4

Ejemplares similares